Table 1.
Number of patients | 56 |
---|---|
Age, years, median (IQR) | 1.8 (0.2-6.9) |
Age groups | |
<1 year | 23 (41%) |
<2 months | 12 (21%) |
1–4 years | 15 (27%) |
5–9 years | 10 (18%) |
10–13 years | 8 (14%) |
Male gender | 36 (64%) |
Omani nationality | 55 (98%) |
Governorate | |
Muscat | 31 (55%) |
North Batinah | 10 (18%) |
Dakhiliyah | 9 (16%) |
South Batinah | 5 (9%) |
Sharqiyah | 1 (2%) |
Dhahirah | 0 |
Buraimi | 0 |
Wusta | 0 |
Dhofar | 0 |
History of travel | 0 |
History of contact with a known case of COVID-19 | 38 (68%) |
Immediate vs extended family members | 29 vs 5a |
Underlying medical condition | 22 (39%) |
Sickle cell disease | 7 (13%) |
Severe neurologic impairment | 4 (7%) |
Asthma | 2 (4%) |
Immunocompromised | 2 (4%) |
Cystic fibrosis | 2 (4%) |
Congenital heart disease | 1 (2%) |
Prematurity | 1 (2%) |
Other | 5 (9%) |
COVID-19 illness classification | |
Uncomplicated disease | 38 (68%) |
Pneumonia | 13 (23%) |
Severe pneumonia | 5 (9%) |
MIS-C | 5 (9%) |
Level of care required | 38 (68%) |
Regular ward bed | 45 (80%) |
High dependency bed | 4 (7%) |
Intensive care | 7 (13%) |
Days in intensive care, median (IQR) | 3 (2-8) |
Hospital length of stay, days, median (IQR) | 2 (1-4) |
Complications | 15 (27%) |
Sickle cell disease-related complications2 | 7 (13%) |
Seizure | 3 (5%) |
Acute kidney injury | 2 (4%) |
Myocardial dysfunction | 1 (2%) |
Shock | 1 (2%) |
Acute respiratory distress syndrome | 1 (2%) |
Subdural hematoma (associated with trauma) | 1 (2%) |
Acute appendicitis | 2 (4%) |
Death or chronic morbidity | 0 (0%) |
Degree of relatedness of the known contact was not specified in 4 cases. For 18 cases, contact with a known case of COVID-19 was not mentioned. 2Three patients’ course was complicated by acute chest syndrome, 2 with splenic sequestration, while vaso-occlusive pain crisis and acute anemia requiring transfusion were observed in 1 patient each.